VILINBIO — Vilin Bio Med Balance Sheet
0.000.00%
- IN₹385.02m
- IN₹388.70m
- IN₹148.10m
- 44
- 22
- 82
- 47
Annual balance sheet for Vilin Bio Med, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.465 | 0.39 | 0.345 | 60.5 | 0.561 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 89.1 | 86.2 | 106 | 68.6 | 70.1 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 120 | 119 | 133 | 186 | 126 |
| Net Property, Plant And Equipment | 18.7 | 16.5 | 15.1 | 13.8 | 28.5 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 139 | 136 | 177 | 324 | 277 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 54.6 | 53.7 | 65 | 92.7 | 45.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 65.3 | 61.6 | 70.1 | 95.6 | 46.6 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 73.6 | 74 | 107 | 228 | 231 |
| Total Liabilities & Shareholders' Equity | 139 | 136 | 177 | 324 | 277 |
| Total Common Shares Outstanding |